Peru vs Switzerland: Prevalence rate of hypertension in adults aged 30-79
Peru
20.7
in 2019
Switzerland
21.9
in 2019
Peru rank
194th
Switzerland rank
193rd
Prevalence rate of hypertension in adults aged 30-79 over time
- Peru
- Switzerland
How they compare
Switzerland currently reports 21.9 against 20.7 in Peru, a difference of 1.2.
That makes Switzerland's figure about 1.1 times Peru's.
Across all 30 years both countries report, Switzerland has been ahead every year.
Peru ranks 194th and Switzerland ranks 193rd of 194 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Peru | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 20.11 | 32.69 | 12.58 | Switzerland |
| 2000s | 19.85 | 29.3 | 9.45 | Switzerland |
| 2010s | 20.06 | 24.31 | 4.25 | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in adults aged 30-79, Peru or Switzerland?
- Switzerland, at 21.9 against 20.7 in Peru as of 2019.
- What is the difference in prevalence rate of hypertension in adults aged 30-79 between Peru and Switzerland?
- 1.2, with Switzerland ahead.
- How many years of comparable data are there for Peru and Switzerland?
- 30 years are reported by both, from 1990 to 2019.
- How do Peru and Switzerland rank globally for prevalence rate of hypertension in adults aged 30-79?
- Peru ranks 194th and Switzerland ranks 193rd of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in adults aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of the population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.